Reviva Pharmaceuticals Holdings, Inc. – NASDAQ:RVPHW

Reviva Pharmaceuticals Holdings stock price today

$0.049
-0.13
-72.61%
Financial Health
0
1
2
3
4
5
6
7
8
9

Reviva Pharmaceuticals Holdings stock price monthly change

-28.00%
month

Reviva Pharmaceuticals Holdings stock price quarterly change

-28.00%
quarter

Reviva Pharmaceuticals Holdings stock price yearly change

-87.14%
year

Reviva Pharmaceuticals Holdings key metrics

Market Cap
 54.47M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -1.71
Revenue
 N/A
EBITDA
 -36.49M
Income
 -37.65M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Reviva Pharmaceuticals Holdings stock price history

Reviva Pharmaceuticals Holdings stock forecast

Reviva Pharmaceuticals Holdings financial statements

Profit Margin

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW): Profit margin
Dec 2022 0 -8.11M
Mar 2023 0 -6.60M
Jun 2023 0 -12.44M
Sep 2023 0 -10.49M
RVPHW income statement history

Debt to Assets

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW): Debt to assets
Dec 2022 18923675 6.60M 34.92%
Mar 2023 12901523 7.11M 55.16%
Jun 2023 11842022 10.22M 86.31%
Sep 2023 5387041 13.90M 258.15%
RVPHW balance sheet history

Cash Flow

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW): Cash Flow
Sep 2022 -4.00M 0 7.77M
Dec 2022 -4.69M 0 18.56K
Mar 2023 -7.95M 0 687.09K
Jun 2023 -5.31M 0 5.21M
RVPHW cash flow history

Reviva Pharmaceuticals Holdings alternative data

Reviva Pharmaceuticals Holdings
Employees

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW): Employee count
Jan 2024 10
Feb 2024 10
Mar 2024 10
Apr 2024 10
May 2024 15
Jun 2024 15
Jul 2024 15

Reviva Pharmaceuticals Holdings other data

Reviva Pharmaceuticals Holdings
Hedge Funds Holdings Q1 2023

0.01% -1.30%
of RVPHW is owned by hedge funds
1 -3
hedge funds hold RVPHW stock
1.67K -191.69K
shares is hold by hedge funds
RVPHW hedge funds holdings changes

Frequently Asked Questions (FAQ)

  • What's the price of Reviva Pharmaceuticals Holdings stock today?

    One share of Reviva Pharmaceuticals Holdings stock can currently be purchased for approximately $0.05.

  • When is Reviva Pharmaceuticals Holdings's next earnings date?

    Unfortunately, Reviva Pharmaceuticals Holdings's (RVPHW) next earnings date is currently unknown.

  • Does Reviva Pharmaceuticals Holdings pay dividends?

    No, Reviva Pharmaceuticals Holdings does not pay dividends.

  • How much money does Reviva Pharmaceuticals Holdings make?

    Reviva Pharmaceuticals Holdings has a market capitalization of 54.47M.

  • What is Reviva Pharmaceuticals Holdings's stock symbol?

    Reviva Pharmaceuticals Holdings, Inc. is traded on the NASDAQ under the ticker symbol "RVPHW".

  • What is Reviva Pharmaceuticals Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Reviva Pharmaceuticals Holdings?

    Shares of Reviva Pharmaceuticals Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Reviva Pharmaceuticals Holdings have?

    As Jul 2024, Reviva Pharmaceuticals Holdings employs 15 workers, which is 50% more then previous quarter.

  • What is Reviva Pharmaceuticals Holdings's official website?

    The official website for Reviva Pharmaceuticals Holdings is revivapharma.com.

  • How can i contact Reviva Pharmaceuticals Holdings?

    Reviva Pharmaceuticals Holdings can be reached via phone at +40 85018881.

Reviva Pharmaceuticals Holdings company profile:

Reviva Pharmaceuticals Holdings, Inc.

revivapharma.com
Exchange:

NASDAQ

Full time employees:

15

Industry:

Biotechnology

Sector:

Healthcare

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

+40 85018881
19925 Stevens Creek Boulevard
Cupertino, 95014

CIK: 0001742927
ISIN: US76152G1186
CUSIP: 76152G118